Skip to content
London Reels Point

Providing Stem Cells During Pregnancy to Infants with Neural Tube Defect Improves Life Outcomes, Study Reveals

A pioneering medical trial has discovered that providing pluripotent cells to fetuses affected by spina bifida during corrective surgery could constitute a "significant breakthrough" in managing prenatal disorders.

Study Parameters and Security

The US-based trial involved six fetuses with a severe neural tube defect. Doctors administered placenta-derived mesenchymal stem cells on the exposed area of the baby's spinal cord during the repair procedure.

Importantly, the regenerative treatment proved to be secure. The study team reported that the therapy did not induce tumors, hinder surgical recovery, or impede the resolution of related neurological issues.

Positive Developments

Magnetic resonance imaging performed on the newborns indicated a successful correction of brainstem displacement in all six infants. This favorable anatomical change is strongly associated with enhanced physical outcomes.

"If it makes additional babies to achieve ambulation who wouldn't have, then it would become the conventional approach," said the lead researcher. "The results are extremely promising and open the door to numerous possible novel therapies."

Future Implications and Hope

Commentators reviewing the findings proposed that subsequent studies of these noted improvements could herald a "different age" in prenatal intervention. The potential to improve neurological damage occurring during fetal development is considered a paradigm-shifting aim.

Particularly welcome would be improvements in urogenital and gastrointestinal outcomes, which are common challenges for individuals living with this defect.

The Path Forward

Although this preliminary study involved a limited number of patients, its established security and encouraging indicators create a solid basis for broader investigative efforts. The addition of cellular treatment with current in-utero repair procedures presents significant potential for transforming outcomes for babies yet to be born with myelomeningocele.

AC
About the author

Allison Caldwell

Avid angler and film enthusiast, exploring London's hidden gems since 2010.

London Reels Point

Type to search articles.